Windtree Therapeutics (WINT) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. application number 18/150,870 directed to “ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WINT:
- Windtree Therapeutics files patent in India for cardiac arrythmia therapy
- Windtree Therapeutics Inc trading halted, news pending
- Windtree Therapeutics Announces Reverse Stock Split Approval
- Windtree Therapeutics board approves 1-for-50 reverse stock split
- Windtree Therapeutics files to sell 40M shares of common stock for holders